3Freston JW,Pilmer BL,Chiu YL,et al. Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole[J]. Aliment Pharmacol Ther, 2004,19 : 1111.
4Otani Y, Kitajima M, Sugiyama M. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress [J]. J Clin Gastroenterol, 1995,20(Suppl 2) :S17.
5Vreeburg E M , L EV Im , Rauw S E A , et al. Enhanced mucosal fibrino lytic activity in gastroduedeual ulcer haemo rrhage and the beneficial effect of acid suppression [ J]. Aliment Phamacol Ther, 2001, 15 (5) : 639-646.
7Freston JW, Pilmer BI, Chiu YI, et al.Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole [J]. Aliment Pharmacol Fher,2004,19(10):1111.
8Otani Y, Kitajima M, Sugiyama M. Inhibitory effects of intravenous lansoprazole on gastriccid hypersecretion in patients with postoperative stress [J]. J Clin Gastroenterol,1995,20(2):S17.
